1-7 of 7
Michelle S. Hirsch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis

Jacob E. Berchuck, Sylvan C. Baca, Heather M. McClure, Keegan Korthauer, Harrison K. Tsai, Pier Vitale Nuzzo, Kaitlin M. Kelleher, Monica He, John A. Steinharter, Soumya Zacharia, Sandor Spisak, Ji-Heui Seo, Vincenza Conteduca, Olivier Elemento, Joonghoon Auh, Michael Sigouros, Eva Corey, Michelle S. Hirsch, Mary-Ellen Taplin, Toni K. Choueiri, Mark M. Pomerantz, Himisha Beltran, Matthew L. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 928–938.
https://doi.org/10.1158/1078-0432.CCR-21-3762
Published: 03 March 2022
View article titled, Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis
Open the PDF for Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis in another window
Includes: Supplementary data
Journal Articles

Abstract B27: Cellular retinoic acid binding protein 2 (CRABP2) is a novel biomarker and potential therapeutic target for high-grade serous ovarian carcinomas

Yi Feng, Michael Gillette, Eric Kuhn, David Klinkebiel, Marilyn A. Mitchell, Kai Doberstein, Daniele Chaves-Moreira, Sho Sato, Haineng Xu, Brett Bomwell, Michelle S. Hirsch, Carolina Reyes, Adam R. Karpf, Michael J. Birrer, Steven J. Skates, Steven A. Carr, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B27.
https://doi.org/10.1158/1557-3265.OVCA19-B27
Published: 01 July 2020
View article titled, Abstract B27: Cellular retinoic acid binding protein 2 (CRABP2) is a novel biomarker and potential therapeutic target for high-grade serous ovarian carcinomas
Journal Articles

Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer

Douglass W. Tucker, Christopher R. Getchell, Eric T. McCarthy, Anders W. Ohman, Naoko Sasamoto, Shuyun Xu, Joo Yeon Ko, Mamta Gupta, Amy Shafrir, Jamie E. Medina, Jonathan J. Lee, Lauren A. MacDonald, Ammara Malik, Kathleen T Hasselblatt, Wenjing Li, Hong Zhang, Samuel J. Kaplan, George F. Murphy, Michelle S. Hirsch, Joyce F. Liu, Ursula A. Matulonis, Kathryn L. Terry, Christine G. Lian, Daniela M. Dinulescu
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1389–1401.
https://doi.org/10.1158/1078-0432.CCR-17-1958
Published: 14 March 2018
View article titled, Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer
Open the PDF for Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A11: Common links suggest a shared embryologic origin for pancreatic and ovarian mucinous tumors

Intidhar Labidi-Galy, Kevin M. Elias, Allison F. Vitonis, Jason L. Hornick, Leona A. Doyle, Michelle S. Hirsch, Daniel W. Cramer, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A11.
https://doi.org/10.1158/1078-0432.OVCA13-A11
Published: 13 May 2014
View article titled, Abstract A11: Common links suggest a shared embryologic origin for pancreatic and ovarian mucinous tumors
Journal Articles

Abstract PR02: Cyclin E1 deregulation occurs early during fallopian tube tumorigenesis and promotes secretory cell transformation

Alison M. Karst, Paul M. Jones, Natalie Vena, Azra H. Ligon, Joyce F. Liu, Michelle S. Hirsch, Dariush Etemadmoghadam, David D. Bowtell, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): PR02.
https://doi.org/10.1158/1078-0432.OVCA13-PR02
Published: 13 May 2014
View article titled, Abstract PR02: Cyclin E1 deregulation occurs early during fallopian tube tumorigenesis and promotes secretory cell transformation
Journal Articles

Abstract A71: Expression of Sushi Domain Containing 2 (SUSD2) in high-grade ovarian serous carcinoma correlated with increased longevity of patients

Jennifer A. A. Gubbels, Elizabeth M. Hultgren, Jessica Johnson, Emily Johnson, Jeffrey Sachs, Michelle S. Hirsch, Joyce Liu, Ronny Drapkin, Kristi A. Egland
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A71.
https://doi.org/10.1158/1078-0432.OVCA13-A71
Published: 13 May 2014
View article titled, Abstract A71: Expression of Sushi Domain Containing 2 (SUSD2) in high-grade ovarian serous carcinoma correlated with increased longevity of patients
Journal Articles

Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

Michael J. Callahan, Zoltan Nagymanyoki, Tomas Bonome, Michael E. Johnson, Babak Litkouhi, Elizabeth H. Sullivan, Michelle S. Hirsch, Ursula A. Matulonis, Joyce Liu, Michael J. Birrer, Ross S. Berkowitz, Samuel C. Mok
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7667–7673.
https://doi.org/10.1158/1078-0432.CCR-08-0479
Published: 01 December 2008
View article titled, Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
Open the PDF for Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer in another window